Abstract
Caesarean section is one of the most commonly performed major operations on women worldwide. Operative morbidity includes haemorrhage, anaemia, blood transfusion and in severe cases, maternal death. Various clinical guidelines address oxytocin use at the time of caesarean section. We previously reported wide variation in practice amongst clinicians in the United Kingdom in the use of oxytocin at caesarean section. The aim of this current study was to determine whether the variation in approach is universal across the individual countries of Great Britain and Ireland and whether this reflects differences in interpretation and implementation of clinical practice guidelines.
| Original language | English |
|---|---|
| Pages (from-to) | 121-4 |
| Number of pages | 4 |
| Journal | European Journal of Obstetrics & Gynecology and Reproductive Biology |
| Volume | 148 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2010 |
Fingerprint
Dive into the research topics of 'Implementation of guidelines on oxytocin use at caesarean section: a survey of practice in Great Britain and Ireland'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver